Shareprice
16 Apr 2026

Press & news

FluoGuide develops surgical solutions that are expected to reduce suffering for the patient and increase the likelihood of cure as well as reducing costs for the health care system.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

2023

30 August, 2023 FluoGuide A/S publishes interim report for the period January – June 2023 News English Regulatory Listing Regulation Report Interim Q2 IR
Copenhagen, Denmark, 30 August 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its...
29 August, 2023 FluoGuide reports further positive interim data from phase IIa trial of FG001 in head & neck cancer News Corporate Action Other English Regulatory MAR IR
Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a pioneer in the cutting-edge field...
28 August, 2023 FluoGuide completes patient enrollment and treatment in FG001 phase llb clinical trial in aggressive brain cancer News Corporate Information Other Corporate Information English IR
Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a pioneer in the cutting-edge field...
28 August, 2023 FluoGuide A/S issues warrants to the investors participating in the directed share issue News Corporate Information Other Corporate Information English Regulatory Listing Regulation IR
Copenhagen, Denmark, 28 August 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce...
31 July, 2023 FluoGuide A/S issues warrants to Board members, management and employees News Corporate Action Other English Regulatory Listing Regulation IR
Copenhagen, Denmark, 31 July 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce...
25 July, 2023 Minutes from Extraordinary General Meeting in FluoGuide A/S News Corporate Information Other Corporate Information English Regulatory Listing Regulation IR
Copenhagen, Denmark, 25 July 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) held an extraordinary...
7 July, 2023 FluoGuide convenes an extraordinary general meeting News Corporate Information General meeting Notice English Regulatory Listing Regulation IR
Copenhagen, Denmark, 7 July 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) hereby invites shareholders...
5 July, 2023 FluoGuide completes a Directed Share Issue raising SEK 15 million News Corporate Action Shares Issuance English Regulatory MAR IR
FluoGuide A/S (“FluoGuide” or the “Company”), a Danish biotech company that pioneers precision cancer surgery...
20 June, 2023 FluoGuide announces positive interim results from phase IIa trial of FG001 in head & neck cancer News Corporate Information Other Corporate Information English IR
FluoGuide A/S (“FluoGuide” or the “Company”), a Danish biotech company that pioneers precision cancer surgery...

FluoGuideCalendar & events